Painkillers an OD risk

AUSTRALIA’S medicines regulator is reviewing the sale of slow-release paracetamol products after concerns were raised about the potential for overdose.

The European Medicines Agency this week recommended the modified or prolongedrelease paracetamol products, such as Panadol Osteo, should be removed from the market because of the complex way the analgesic is released in the body. The Therapeutic Goods Administration said it was reviewing the recommendation “to determine what, if any, action is required in Australia’’.